No. 3 Texas A&M swept No. 1 Kentucky to win the 2025 DI women's volleyball championship on Sunday, Dec. 21 at the T-Mobile Center in Kansas City, Missouri. Both programs earned their spot in the final ...

It's been just over a year since Oura announced a partnership with Medicare Advantage insurer Essence Healthcare, and, now, the partners are looking to continue building on that foundation. The ...

A phase 3 trial of Pharvaris’ deucrictibant has hit its primary endpoint, positioning the biotech to file for approval of a challenger to KalVista Pharmaceuticals’ Ekterly in a rare genetic disease.

We're still on Thanksgiving weekend, so it figures to remain a slow period of the Major League Baseball offseason before things, hopefully, start to pick up sometime next week. Still, there's been a ...

As employers continue to face elevated health benefits costs, Nomi Health is teaming up with Henry Ford Health to rethink the traditional paradigm. Henry Ford has signed on to join Nomi's direct ...

Tempero Bio has hit the brakes on a phase 2-stage alcohol use disorder (AUD) candidate while the biotech considers its options, according to the program’s partner. The mGluR5 negative allosteric ...

Halozyme Therapeutics has been busy. While fighting a patent dispute with Merck & Co. and navigating the impact of the Inflation Reduction Act (IRA), the company has penned an acquisition of fellow ...

If you've ever taken a look at Tamron lenses, you've likely noticed a surprisingly long string of numbers and letters in the product name. Reading "Tamron 18-300mm F/3.5-6.3 Di III-A VC VXD" can feel ...

Family-style Italian restaurant Tony’s Di Napoli plans to venture out of the Big Apple for the first time in more than three decades. With two New York City locations — in Times Square and the Upper ...

Tamron's 18-300mm F3.5-6.3 Di III-A VC VXD APS-C lens is now available for Canon's RF and Nikon's Z mount. When the company announced the new mount options for the lens earlier this year, it caused a ...